Center for Asian Health Equity, The University of Chicago, Chicago, Illinois.
RTI International, Waltham, Massachusetts.
Cancer. 2018 Nov 1;124(21):4137-4144. doi: 10.1002/cncr.31690. Epub 2018 Oct 25.
This report details the cost effectiveness of a non-nurse patient navigation (PN) program that was implemented at the University of Chicago Medical Center to increase colonoscopy-based colorectal cancer (CRC) screening.
The authors investigated the impact of the PN intervention by collecting process measures. Individuals who received navigation were compared with a historic cohort of non-navigated patients. In addition, a previously validated data-collection instrument was tailored and used to collect all costs related to developing, implementing, and administering the program; and the incremental cost per patient successfully navigated (the cost of the intervention divided by the change in the number who complete screening) was calculated.
The screening colonoscopy completion rate was 85.1% among those who were selected to receive PN compared with 74.3% when no navigation was implemented. With navigation, the proportion of no-shows was 8.2% compared with 15.4% of a historic cohort of non-navigated patients. Because the perceived risk of noncompletion was greater among those who received PN (previous no-show or cancellation, poor bowel preparation) than that in the historic cohort, a scenario analysis was performed. Assuming no-show rates between 0% and 50% and using a navigated rate of 85%, the total incremental program cost per patient successfully navigated ranged from $148 to $359, whereas the incremental intervention-only implementation cost ranged from $88 to $215.
The current findings indicate that non-nurse PN can increase colonoscopy completion, and this can be achieved at a minimal incremental cost for an insured population at an urban academic medical center.
本报告详细介绍了芝加哥大学医疗中心实施的非护士患者导航(PN)计划的成本效益,该计划旨在提高基于结肠镜检查的结直肠癌(CRC)筛查率。
作者通过收集过程指标来调查 PN 干预的影响。接受导航的个体与未接受导航的历史队列患者进行了比较。此外,还对以前验证的数据收集工具进行了调整,用于收集与开发、实施和管理该计划相关的所有成本;并计算了每位成功接受导航的患者的增量成本(干预成本除以完成筛查的人数变化)。
与未实施导航时相比,选择接受 PN 的患者的筛查结肠镜完成率为 85.1%,而未实施导航时为 74.3%。在实施了导航后,未出现的比例为 8.2%,而历史队列中未接受导航的患者为 15.4%。由于接受 PN 的患者(之前未出现或取消、肠道准备不佳)的非完成风险感知更高,因此进行了方案分析。假设未出现率在 0%至 50%之间,并且采用 85%的导航率,每位成功接受导航的患者的总增量计划成本为 148 美元至 359 美元,而增量干预仅实施成本则在 88 美元至 215 美元之间。
目前的研究结果表明,非护士 PN 可以提高结肠镜检查的完成率,而对于城市学术医疗中心的参保人群,这可以以最小的增量成本实现。